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ABSTRACT
Bromodomain-containing protein 2 (Brd2) is a BET family chromatin
adaptor required for expression of cell-cycle-associated genes and
therefore involved in cell cycle progression. Brd2 is expressed in
proliferating neuronal progenitors, displays cell-cycle-stimulating
activity and, when overexpressed, impairs neuronal differentiation.
Paradoxically, Brd2 is also detected in differentiating neurons. To
shed light on the role of Brd2 in the transition from cell proliferation to
differentiation, we had previously looked for proteins that interacted
with Brd2 upon induction of neuronal differentiation. Surprisingly, we
identified the growth factor pleiotrophin (Ptn). Here, we show that Ptn
antagonized the cell-cycle-stimulating activity associated with Brd2,
thus enhancing induced neuronal differentiation. Moreover, Ptn
knockdown reduced neuronal differentiation. We analyzed Ptn-
mediated antagonism of Brd2 in a cell differentiation model and in
two embryonic processes associated with the neural tube: spinal cord
neurogenesis and neural crest migration. Finally, we investigated the
mechanisms of Ptn-mediated antagonism and determined that Ptn
destabilizes the association of Brd2 with chromatin. Thus, Ptn-
mediated Brd2 antagonism emerges as a modulation system
accounting for the balance between cell proliferation and
differentiation in the vertebrate nervous system.
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INTRODUCTION
Proper coordination between cell proliferation and differentiation is
crucial for development and growth of living organisms. Accurate
control of these processes is a challenge for regenerative medicine
when applying cell therapies. Members of the bromodomain
and extra terminal (BET) family of transcriptional co-regulators
have essential roles in cell cycle progression (Belkina et al.,
2014; LeRoy et al., 2008; Mochizuki et al., 2008; Yang et al.,
2008). Interestingly, some BET members have been additionally
associated with cell differentiation. In this regard, the family
member bromodomain-containing protein 2 (Brd2), besides
interacting with the transcription factor E2F and controlling
expression of cyclin A2 and D1 in proliferating cells (Belkina
et al., 2014; Denis et al., 2000; Garcia-Gutierrez et al., 2012; LeRoy
et al., 2008; Sinha et al., 2005), is expressed in differentiating
neurons (Crowley et al., 2004), which might be linked to the neural
tube closure defects observed in Brd2-knockout mouse embryos
and to the association of mutations in the BRD2 locus with human
juvenile myoclonic epilepsy (Gyuris et al., 2009; Shang et al.,
2009; Velı´sˇek et al., 2011).
Four BET proteins have been described in vertebrates, Brd2,
Brd3, Brd4 and Brdt, which are broadly expressed with the
exception of Brdt, where expression is restricted to the male germ
line (Crowley et al., 2004; Rhee et al., 1998; Shang et al., 2004;
Taniguchi et al., 1998). BET proteins, by means of two N-terminal
bromodomains, recognize and associate with acetylated histones
on chromatin (Kanno et al., 2004). In contrast to most proteins,
including other bromodomain-containing proteins, some of the
BET family members have the ability to remain attached to the
chromosomes during mitosis (Dey et al., 2003), suggesting they
have an epigenetic function. Although binding of BET proteins to
the chromatin depends on the integrity of the bromodomains
(Kanno et al., 2004), we have recently reported that dimerization
through motif B is also required (Garcia-Gutierrez et al., 2012).
Knockout mice of BET family members have highlighted the
relevance of these proteins for development and survival. Thus,
Brd4 and Brd2 mutant mice die at early post-implantation and
E11.5 stages, respectively (Houzelstein et al., 2002; Shang et al.,
2009). Mouse embryonic fibroblasts derived from Brd4 and Brd2
mutant embryos display proliferative defects, which, to a lesser
extent, are also observed in heterozygous cells (Houzelstein et al.,
2002; Shang et al., 2009). In addition, knockdown of Brd4 in
cultured cells leads to cell cycle arrest (Mochizuki et al., 2008;
Yang et al., 2008). Interestingly, reduced expression of Brd2 in
mice produces a distinct hypomorphic phenotype with extreme
obesity and hyperinsulinemia, but enhanced glucose tolerance and
low blood glucose (Wang et al., 2010).
In the developing neural tube, proliferation occurs in the
ventricular zone, close to the lumen, and neuronal differentiation
requires proliferating progenitors to exit the cell cycle and,
subsequently, migrate to the pial surface, or mantle layer, to
accomplish differentiation. Besides being expressed in neural
progenitors, Brd2 is also detected in differentiating neurons of the
mantle layer in the developing spinal cord (Crowley et al., 2004). It
has been reported that Brd2 stimulates cell cycle progression (Sinha
et al., 2005), and in fact, we have shown that overexpressing Brd2
impairs neuronal differentiation, as it results in elevated expression
levels of cyclin D1 and A2 (Garcia-Gutierrez et al., 2012). Thus,
the prominent role Brd2 displays during cell proliferation raises the
question about its presence in differentiating neurons. To reconcile
these observations and to better understand Brd2 function we have
looked for Brd2-interacting proteins. From a previous two-hybrid
screening (Garcia-Gutierrez et al., 2012), we identified pleiotrophin
(Ptn) as a Brd2-interacting protein, and chose to study it because it
is expressed in P19 cells following induction of neuronal
differentiation (Brunet-de Carvalho et al., 2003).
Ptn is abundantly expressed in the developing nervous system,
and together with its homologue midkine (Mdk), comprise a
family of secreted heparin-binding growth factors (Kadomatsu
and Muramatsu, 2004). Its neuroprotective properties, together
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with its capacity to promote neurite outgrowth, are important for
nerve regeneration (Jin et al., 2009). In this work, we describe
Ptn–Brd2 interaction during neuronal differentiation. Our results
indicate that Ptn enhances induced neuronal differentiation
by antagonizing Brd2 cell-cycle-stimulating activity. Thus,
we propose that Ptn-mediated antagonism accounts for the
occurrence of neuronal differentiation in the presence of Brd2.
RESULTS
Ptn interacts with Brd2
To obtain insight into the function of Brd2 and in particular, to
begin to explain how the role of Brd2 in regulating the cell cycle
can be understood in light of its presence in differentiating
neurons, we previously had performed a yeast two-hybrid
screening with an 11-day-old mouse embryo cDNA library
(Garcia-Gutierrez et al., 2012). At this stage, development of the
neural tube is advanced and contains both neural progenitors and
differentiating neurons. Among the Brd2 partners we identified
was Ptn, previously shown to be expressed following retinoic acid
(RA)-mediated induction of neuronal differentiation in mouse
teratocarcinoma P19 cells (Brunet-de Carvalho et al., 2003).
Interaction in yeast was confirmed by growth in selective medium
and b-galactosidase staining of positive clones (Fig. 1A,B). To
analyze interaction in mammalian cells we co-expressed HA- and
Flag-tagged versions of Ptn and Brd2, respectively, in 293T cells.
Immunoprecipitation with anti-Flag antibodies demonstrated co-
precipitation of Ptn–HA only when Flag–Brd2 was expressed
(Fig. 1C). To analyze direct interaction between both proteins we
conducted in vitro pulldown experiments by incubating a
fragment of Brd2, expressed and purified from E. coli as a
histidine tail fusion protein, with either purified GST or a GST–
Ptn fusion protein. Results revealed Brd2 co-precipitation only in
the presence of GST–Ptn, indicating direct interaction between
these proteins (Fig. 1D). As Ptn shows a substantial degree of
conservation with the other family member Mdk, we asked
whether Brd2 could also interact with Mdk. Immunoprecipitation
analysis indicated that Brd2 also precipitated Mdk (Fig. 1E).
Next, we wished to map the regions of interaction between Brd2
and Ptn. Given that the C-terminal region of Ptn has been revealed
as a functional domain (Bernard-Pierrot et al., 2001; Zhang et al.,
1999), we analyzed the interaction between Brd2 and Ptn protein
lacking this domain by yeast two-hybrid assays. Our results
indicated that the C-terminus of Ptn is required for this interaction
(Fig. 1F). Because this domain is rich in basic amino acids, we
speculated about the involvement of an acidic region of Brd2 in the
interaction. We therefore divided our two-hybrid Brd2 construct
into two fragments: the small acidic region and rest of the protein
(Fig. 1A). Analysis in yeast two-hybrid assays indicated that the
acidic region was necessary and sufficient to mediate interaction
with Ptn (Fig. 1F). Interestingly, the acidic region found in Brd2
seems to be absent from other BET family members, which
prompted us to investigate the interaction of Ptn with other BET
proteins. Yeast two-hybrid analysis indicated that Ptn did not
interact with Brd3 or Brd4, indicating that Ptn interaction was
specific to Brd2 (Fig. 1F). To confirm these results, we analyzed
interaction in 293T cells by immunoprecipitation, and found that
Ptn–HAwas efficiently precipitated by Flag–Brd2 but not by Flag–
Brd3 or Flag–Brd4 (Fig. 1G). In agreement with these results, a
deletion mutant of Brd2 lacking the acidic region (Brd2Dacid) was
also unable to precipitate Ptn–HA (Fig. 1G).
Finally, we wished to determine whether there was an
interaction between endogenous Brd2 and Ptn proteins. For that
we turned to P19 cells, where expression of Ptn has been reported
following RA treatment (Brunet-de Carvalho et al., 2003). Co-
immunoprecipitation of endogenous Ptn was observed when
lysates were immunoprecipitated using an anti-Brd2 antibody but
not with the corresponding pre-immune serum (Fig. 1H),
demonstrating interaction of the endogenous proteins.
Brd2 and Ptn are coexpressed in P19 cells that are
differentiating into neurons
We next analyzed the expression levels of Brd2 and Ptn in P19
cells under normal growth conditions, in which cells are
proliferating, and after 2 or 4 days of RA treatment, which
leads to cell cycle exit prior to neuronal differentiation.
Immunoblot analysis revealed Ptn expression only after RA
treatment, peaking at 2 days, in agreement with previous reports
(Fig. 2A; Brunet-de Carvalho et al., 2003). In contrast, no
changes in Brd2 expression were observed throughout the
differentiation protocol (Fig. 2A). The pluripotency marker Oct-
3/4 (also known as POU5F1) and the neuronal marker bIII-
tubulin were used as controls for differentiation. Rapid
downregulation of Oct-3/4 was observed at day 2 of treatment
and accumulation of bIII-tubulin was observed at day 4, whereas
no changes were detected in expression of the housekeeping
marker a-tubulin (Fig. 2A). Thus, under proliferating conditions,
Brd2 and Ptn are not co-expressed in P19 cells, but they are
following RA treatment. We next analyzed their expression by
immunofluorescence, observing again coexpression under
differentiation conditions (Fig. 2B). Ptn was only detected in
differentiating cells, both in the cytoplasm and the nucleus,
whereas Brd2 was detected in both conditions: clearly restricted
to the nucleus in proliferating cells and partially localized to the
cytoplasm in differentiating cells. To confirm cellular localization
of Brd2 and Ptn, cells were subjected to biochemical fractionation
followed by immunoblotting. As controls we analyzed the nuclear
protein BAF155, a SWI/SNF complex subunit also known as
SMARCC1, and a-tubulin, which is essentially cytoplasmic. As
shown in Fig. 2C, biochemical fractionation confirmed the results
observed in immunofluorescence analyses shown in Fig. 2B. As
the reported Brd2 functions are mostly associated with the
nucleus, we wished to determine whether Ptn was present in the
nucleus of differentiating P19 cells, and, to support functional
consequences of the Ptn interaction on Brd2 activity, whether the
endogenous proteins interacted in the nucleus. For that, we
isolated nuclei from RA-treated P19 cells and prepared nuclear
extracts to analyze coprecipitation of Ptn with Brd2. As shown in
Fig. 2D, co-immunoprecipitation experiments confirmed Ptn–
Brd2 interaction in the nucleus. To have an idea of the Ptn:Brd2
ratio in the cell we compared relative levels of Ptn and Brd2 in
protein extracts from P19 cells treated for 2 days with RA. Levels
were determined from immunoblotting quantification of samples
loaded together with known amounts of purified Ptn and Brd2
proteins. Analysis was performed on both whole-cell and nuclear
extracts. Results indicate that in whole-cell extracts, levels of Ptn
were,4-fold those of Brd2; however, in the nucleus the ratio was
close to 1:1 (Fig. 2E).
Ptn stimulates neuronal differentiation by antagonizing Brd2
The detection of bIII-tubulin in P19 cells transfected with
expression constructs for the neurogenic factors NeuroD2 and
E12 (also known as Tcf3) represents a way to evaluate neuronal
differentiation (Farah et al., 2000). Using this system we have
previously reported inhibition of neuronal differentiation by
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ectopic Brd2 expression (Garcia-Gutierrez et al., 2012). As Ptn
interacts with Brd2 and is detected upon induction of neuronal
differentiation in P19 cells, we wished to explore the functional
consequences of the Ptn–Brd2 interaction in this process. We
therefore co-transfected different Brd2 and Ptn constructs together
with expression constructs for NeuroD2, E12 and GFP in P19 cells,
and quantified neurogenesis as the percentage of transfected cells
(monitored by GFP expression) expressing bIII-tubulin at 3 days
after transfection. As expected, expression of Brd2 impaired
neuronal differentiation (Fig. 3A,B), but, interestingly,
coexpression of Ptn neutralized the effects of Brd2. Surprisingly,
expression of Ptn alone increased neuronal differentiation.
Expression of a fragment of Brd2 encompassing the motif B,
previously shown to interfere with chromatin binding of Brd2
Fig. 1. Brd2 interacts with Ptn through a unique acidic domain. (A) Diagram of the Brd2 bait construct used in the two-hybrid screening. Numbering
indicates amino acid position of relevant domains. BD1, bromodomain 1; BD2, bromodomain 2; mB, motif B; ET, extra terminal domain; NLS, nuclear localization
signal (as described in Guo et al., 2000); SEED, domain rich in acidic/phosphorylatable amino acids. The acidic domain N-terminal to the motif B (acid) and
C-terminal region (Cter) analyzed in F and G are also indicated. (B) Growth on selective and non-selective media of yeast harboring the indicated bait and prey
constructs or empty vectors (LexA and GAD, respectively) as indicated. Interaction was also visualized by blue color in yeast assayed for b-galactosidase
activity. (C) Extracts from 293T cells transfected with hemagglutinin (HA)-tagged Ptn (Ptn–HA) and Flag-tagged Brd2 (Flag–Brd2) constructs or empty vector
were immunoprecipitated with anti-Flag antibodies and the co-immunoprecipitated proteins (coIP) were visualized by immunoblotting with anti-HA antibodies.
The input shows 10% of Flag- or HA-tagged input proteins. (D) Pulldown experiments carried out with immobilized purified GST or a GST–Ptn fusion, and a
66His-tagged Brd2 fragment (Brd2) purified from bacteria. Precipitated Brd2 (retained) was detected by immunoblotting; 20% of Brd2 input protein and 100% of
GST-derived input proteins were detected by immunoblotting and Coomassie Blue staining, respectively. (E) Extracts from 293T cells transfected with Flag–
Brd2, and Ptn–HA or Mdk–HA constructs were immunoprecipitated with anti-Flag antibodies and the co-immunoprecipitated proteins (coIP) were visualized by
immunoblotting with anti-HA antibodies. The input shows 10% of Flag- or HA-tagged input proteins. (F) Growth on selective and non-selective media of yeast
harboring bait and prey constructs or empty vectors as indicated. Deletions (D) refer to Brd2 acidic region (acid) and to Brd2 and Ptn C-terminal domains (Cter).
(G) Extracts from 293T cells transfected with Ptn–HA, and the indicated Flag-tagged constructs were immunoprecipitated with anti-Flag antibodies and the
co-immunoprecipitated proteins (coIP) were visualized by immunoblotting with anti-HA antibodies. The input shows 10% of Flag- or HA-tagged input proteins.
(H) Extracts from P19 cells treated with RA for 48 h were immunoprecipitated with anti-Brd2 antibodies or pre-immune sera, and co-immunoprecipitated
endogenous Ptn was monitored by immunoblotting with anti-Ptn antibodies. The input shows 10% of endogenous input proteins.
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(Garcia-Gutierrez et al., 2012), also led to enhanced differentiation.
Thus, antagonizing endogenous Brd2 enhances neuronal
differentiation, suggesting that Ptn acts by antagonizing Brd2. In
agreement with this possibility, knockdown of endogenous Ptn
(Fig. 3C) resulted in reduced differentiation (Fig. 3A,B). We also
analyzed Brd2 mutants lacking the small acidic region involved in
Ptn interaction (Brd2Dacid). Deletion of this region did not affect
the anti-neurogenic activity of Brd2, but, interestingly, Ptn was
unable to antagonize it. We next considered whether
overexpression of Brd3, a BET family member highly related to
Brd2 but naturally lacking the acidic region, would affect
neurogenesis. We found that Brd3 also impaired neuronal
differentiation, but, similar to the Brd2Dacid molecule, it was
resistant to Ptn antagonism. Ptn, when overexpressed together with
Brd3 or Brd2Dacid, is probably neutralizing endogenous Brd2,
which should result in enhanced neurogenesis. However, as ectopic
Brd3 and Brd2Dacid are insensitive to Ptn antagonism, cell-cycle-
stimulating activity prevails, resulting in impaired neurogenesis.
To estimate Brd2 and Ptn overexpression in these experiments we
analyzed protein levels by immunoblotting in cells transfected with
NeuroD2 and E12 expression constructs, either alone or together
with Brd2 and Ptn expression constructs (Fig. 3D). Quantification
indicated a 2.5-fold increase of both Brd2 and Ptn when
transfecting cells with their expression constructs. However, as
endogenous Brd2 is expressed in all the cells regardless of being
transfected or not, we corrected this value according to transfection
efficiency (65%), and estimated a 3.3-fold increase in transfected
cells. Correction was not necessary for Ptn, because endogenous
Ptn is only detected in transfected cells induced by NeuroD2 and
E12 expression. Finally, we analyzed localization of overexpressed
proteins in differentiating P19 cells. For that we transfected tagged
versions of Brd2 and Ptn together with NeuroD2 and E12
expression constructs, and proteins were visualized by
immunofluorescence. As observed in Fig. 3E localization was
quite similar to that observed for endogenous proteins after 2 days
of RA treatment (Fig. 2B).
Ptn-mediated Brd2 antagonism in the developing neural tube
To analyze the Ptn-mediated Brd2 antagonism in an animal
model we turned to the developing neural tube, where both
proteins, or the corresponding mRNAs, have been previously
reported to be abundantly expressed (Crowley et al., 2004;
DiBenedetto et al., 2008; Mitsiadis et al., 1995; Mittapalli et al.,
2009). For the analysis, we chose the technique of electroporation
of the neural tube in chick embryos, which allows transfection of
neural progenitors in one half of the neural tube with expression
constructs of interest. We have previously reported that
overexpression of Brd2 impairs naturally occurring neuronal
differentiation (Garcia-Gutierrez et al., 2012). Here, we show that
Brd2 overexpression also impairs forced differentiation induced
by expression of the neurogenic factor neurogenin 2 (Ngn2, also
known as Neurog2). As observed in Fig. 4A,B, Ngn2-transfected
cells (GFP positive) localized to the mantle (bIII-tubulin-positive
region), indicative of neuronal differentiation. However, ectopic
expression of Brd2 impaired the Ngn2-mediated effect.
Interestingly, when Ptn was also transfected, a significant
Fig. 2. Brd2 and Ptn are co-expressed in differentiating P19 cells. (A) P19 cells were treated with RA for the indicated times and then collected. Total
lysates were analyzed by immunoblotting using antibodies against the indicated proteins. bIII-Tub, bIII-tubulin; a-Tub, a-tubulin. (B) Localization of
endogenous Brd2 and Ptn in P19 cells under normal growing conditions (Prolif.) or after treatment with RA for 48 h (Diff.) were visualized by
immunofluorescence with anti-Brd2 (red) and anti-Ptn (green) antibodies. DNA was counterstained with DAPI (blue). Scale bars: 10 mm. (C) P19 cells under
normal growing conditions (Prolif.) or after treatment with RA for 48 h (Diff.) were subjected to biochemical fractionation and proteins from cytoplasmic (C) or
nuclear (N) fractions were analyzed by immunoblotting with the indicated antibodies. (D) Co-immunoprecipitation experiments of endogenous Brd2 and Ptn
proteins were conducted as described in Fig. 1H but using nuclear extracts obtained from isolated nuclei of P19 cells treated with RA for 48 h. The input shows
10% of endogenous input proteins. As controls for the purity of the nuclear extract preparation, the levels of the nuclear protein BAF155 and cytoplasmic
protein a-tubulin (a-Tub) were also determined from 10% of the extract. (E) Relative levels of endogenous Ptn and Brd2 proteins were determined from
immunoblotting quantification of whole and nuclear (nucl.) extracts (60 and 30 mg of total protein, respectively) from RA-treated P19 cells, analyzed together with
known amounts of purified Ptn and Brd2 proteins (50, 10 and 2 ng) as described in Fig. 1D. Brd2 levels were normalized to 1. Values are means6s.d. of three
independent determinations.
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recovery in Ngn2-driven neurogenesis was observed, indicative
of Ptn-mediated Brd2 antagonism. Ptn expression, in the absence
of Ngn2, had no effect (Fig. 4A,B), indicating that Ptn is not a
neurogenic factor but stimulates neurogenesis.
Because Brd2 and Ptn are also expressed in neural-crest-
associated structures (for instance in dorsal root ganglia and dorsal
neural tube) (Crowley et al., 2004; Dibenedetto et al., 2008;
Mitsiadis et al., 1995; Mittapalli et al., 2009), we decided to also
study effects of Brd2 and Ptn misexpression in neural crest
migration. Migrating neural crest cells originate from the dorsal-
most region of the neural tube and undergo an epithelial-to-
mesenchymal transition that enables them to delaminate and
migrate into the adjacent mesoderm to create a variety of structures
during development (Dupin and Sommer, 2012). The ventrolateral
pathway at trunk level gives rise to dorsal root ganglia, among
other structures. Electroporation of the dorsal neural tube in
embryos with a reporter construct allows tracing of streams of
migrating neural crest cells; thus, it has been established that
reporter-positive cells in the mesoderm that locate ventrally to the
electroporated dorsal neural tube correspond to migrating neural
crest cells (Atkins et al., 2000). By using this approach, using a
lacZ reporter construct followed by b-galactosidase staining, we
observed, 30 h after electroporation, that ectopic Brd2 expression
had no observable consequences on neural crest migration
(Fig. 5A). However, Ptn overexpression drastically perturbed
normal neural crest migration (Fig. 5A). As Ptn antagonizes
Brd2, we hypothesized that Ptn-mediated interference of neural
crest migration might be a consequence of antagonizing
endogenous Brd2 function, which might be required for neural
crest migration. As Brd2 knockdown (Fig. 5B) or competition with
the peptide encompassing the motif B led to impaired neural crest
migration (Fig. 5A), we conclude that this process requires Brd2.
Finally, we reasoned that if Ptn-mediated impairment of neural
crest migration is due to antagonism of endogenous Brd2,
overexpressing Brd2 should reverse the effects of Ptn. As shown
in Fig. 5A, Brd2 overexpression led to a significant recovery in
neural crest migration.
Ptn destabilizes association of Brd2 with chromatin
As our results indicate that Ptn interferes with Brd2 function, we
wished to explore the mechanisms involved. To this end, we
analyzed the effect of Ptn on the strength of Brd2 attachment to
Fig. 3. Ptn stimulates neuronal differentiation by antagonizing Brd2. (A) P19 cells were transfected with NeuroD2 and E12 expression constructs, together
with a GFP reporter plasmid and the indicated expression constructs, to be tested for expression of the neuronal marker bIII-tubulin. Control corresponds to
empty vector and sh denotes interference by small hairpin RNA molecules. Neurogenesis was evaluated as the percentage of transfected cells (GFP
positive, green) that are bIII-tubulin positive (red). Representative images are displayed. Scale bar: 100 mm. (B) Representation of data from A. Values are
mean6s.d. from three areas of four independent experiments. Statistical significance was assessed by ANOVA, followed by Bonferroni’s post test. Asterisks on
top of columns refer to significance comparing with the corresponding control. **P#0.01, ***P#0.001. (C) P19 cells were transfected with shPtn or
shControl constructs and treated with RA for 48 h. Cell lysates were analyzed by immunoblotting with anti-Ptn and anti-a-tubulin (a-Tub) antibodies. (D) Protein
extracts from cells transfected with NeuroD2 and E12 expression constructs, either alone (control) or together with the Brd2 and Ptn expression constructs used
in A (overexpr.), were analyzed by immunoblotting with antibodies against the indicated proteins. (E) P19 cells were transfected with NeuroD2 and E12
expression constructs, together with Flag-tagged Brd2 (Flag–Brd2) and HA-tagged Ptn (Ptn–HA) expression constructs, and analyzed by immunofluorescence
with anti-Flag (green), anti-HA (red) and anti-bIII-tubulin (cyan) antibodies. DNA was counterstained with DAPI (blue). Images shown are representative of at
least 70% of the analyzed cells. Scale bar: 10 mm.
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chromatin in P19 cells. It has been previously shown that high salt
concentrations are required to extract Brd2 from chromatin
(Denis and Green, 1996; Garcia-Gutierrez et al., 2012).
Therefore, cells transfected with a Ptn expression construct or
empty vector were subjected to sequential protein extraction with
100 mM and 520 mM NaCl. Most of the endogenous Brd2 in
control-transfected cells required 520 mM NaCl to be extracted
in solution (Fig. 6A). However, in the presence of Ptn, most of
the endogenous Brd2 was extracted with 100 mM NaCl,
indicating destabilization of its association with chromatin.
To confirm this observation, we analyzed the occupancy of
Brd2 in the promoter regions of the cyclin A2 and D1 genes,
Fig. 4. Ptn antagonizes Brd2 during neuronal differentiation in the developing neural tube. (A) The neural tube of chick embryos at stage HH17 was
electroporated on the right side with the indicated constructs and neurogenesis was evaluated by immunofluorescence after 30 h on transverse sections of the
spinal cord as the percentage of transfected cells (GFP positive, green) that localize to the mantle layer (ML), the differentiation compartment, where the
neuronal marker bIII-tubulin (red) is expressed. Representative images are displayed. The frontier between the proliferative ventricular zone (VZ) and ML is
indicated by a dashed line in the electroporated side of the GFP control experiment (left upper panel). (B) Representation of data from A. Values are mean6s.d.
from three sections of four independent experiments. Statistical significance was assessed by ANOVA, followed by Bonferroni’s post test. ***P#0.001.
Fig. 5. Ptn-mediated Brd2 antagonism
in neural crest formation. (A) The
dorsal neural tube of chick embryos at
stage HH17 was electroporated on the
right side with a LacZ reporter construct
and the indicated expression constructs,
and migration of neural crest cells was
evaluated by blue staining of embryos
assayed for b-galactosidase activity after
30 h. Representative lateral images from
the embryo trunk (in toto) and transverse
sections at the level of one of the
migratory streams (dashed line) are
shown. (B) The neural tube of chick
embryos at stage HH17 was dorsally
electroporated on the right side with an
shBrd2 construct together with a GFP
reporter plasmid, and expression of
endogenous Brd2 (red) was evaluated in
GFP positive cells (green) by
immunofluorescence using anti-Brd2
antibodies after 30 h on transverse
sections of the spinal cord.
RESEARCH ARTICLE Journal of Cell Science (2014) 127, 2554–2564 doi:10.1242/jcs.147462
2559
Jo
ur
na
l o
f C
el
l S
ci
en
ce
which have been previously shown to be regulated by Brd2
(Belkina et al., 2014; Garcia-Gutierrez et al., 2012; LeRoy et al.,
2008; Sinha et al., 2005), by chromatin immunoprecipitation
(ChIP). RA treatment of P19 cells, which induces Ptn expression,
resulted in Brd2 dissociation from promoters (Fig. 6B). In fact,
expression of Ptn in non-treated cells also caused dissociation,
comparable to that driven by a protein fragment encompassing
the dimerization motif B, previously shown to dissociate Brd2
(Garcia-Gutierrez et al., 2012). Given that the Ptn interaction
domain in Brd2 is close to motif B, we analyzed Ptn interference
on Brd2 dimerization by co-immunoprecipitation of Flag- and
HA-tagged Brd2 proteins molecules in the presence of Ptn. As
illustrated in Fig. 6C, similar to the motif B peptide, the presence
of Ptn protein substantially reduced the ability of Brd2 to
dimerize.
DISCUSSION
The chromatin adaptor Brd2 is an essential regulator associated
with the cell cycle and broadly expressed during development
(Crowley et al., 2004; Denis et al., 2000; Garcia-Gutierrez et al.,
2012; LeRoy et al., 2008; Rhee et al., 1998; Shang et al., 2009;
Sinha et al., 2005). Despite the clear role of Brd2 in cell cycle
progression (Denis et al., 2000; Garcia-Gutierrez et al., 2012;
LeRoy et al., 2008; Shang et al., 2009; Sinha et al., 2005),
expression is also detected in differentiating neurons (Crowley
et al., 2004). To shed light on this apparent paradox, we have tried
to identify new Brd2 partners. Surprisingly, when looking for
Brd2-interacting proteins during neuronal differentiation, we found
the growth factor Ptn. Secreted Ptn has been linked to a variety of
biological processes, and receptor-mediated functions have been
well characterized (Kadomatsu and Muramatsu, 2004). However,
intracellular mechanisms of action directly involving Ptn are
poorly understood. In this study, we have assigned an intracellular
function to Ptn in neuronal differentiation as an antagonist of the
cell-cycle-stimulating factor Brd2. In our model, expression of Ptn
at the onset of neuronal differentiation leads to Brd2 antagonism,
which favors differentiation versus proliferation. To perform a
detailed functional analysis, we have taken advantage of the P19
cell line, as only Ptn, but not Mdk, is detected in neuron-like cells
following RA treatment (Brunet-de Carvalho et al., 2003). An
additional analysis has been conducted in the neural tube, where
the scenario becomes more complicated owing to the partially
overlapping expression patterns shown by Ptn and Mdk, which
might be linked to functional redundancy (Mitsiadis et al., 1995).
In fact, the severe phenotype associated with the double Ptn/Mdk
mutation in mice, in contrast to mild phenotypes in the single
mutants, has been explained on the basis of functional redundancy
and compensation (Muramatsu et al., 2006). We have shown Ptn-
mediated Brd2 antagonism in three different systems: neuronal
differentiation in P19 cells, neurogenesis in the neural tube and
neural crest migration. Unexpectedly, we have also revealed that
Brd2 is required for the last process. An explanation for this might
be found in two observations: Brd2 is required for cyclin D1
expression (LeRoy et al., 2008) and cyclin D1 has been implicated
in neural crest migration (Shoval et al., 2007).
Our model includes several observations and predictions. First,
there are observations and predictions with regard to protein
expression. As previously indicated, Brd2 is detected in
proliferating neuronal progenitors as well as in differentiating
neurons (Crowley et al., 2004). We have also shown that Brd2
levels remain constant during neuronal differentiation of P19 cells.
By contrast, Ptn is detected in P19 cells after RA addition, its
expression peaking at day 2 of treatment, as previously described
(Brunet-de Carvalho et al., 2003), indicating that Ptn expression
follows induction of neuronal differentiation. Expression of Ptn has
also been documented in the developing neural tube of vertebrates
(Mitsiadis et al., 1995; Mittapalli et al., 2009). Expression of
antagonists (i.e. Ptn) of cell-cycle-associated factors (i.e. Brd2) in
postmitotic neurons should prevent the resumption of the cell
cycle, ensuring progression of the differentiation process.
Second, there are observations and predictions with regard to
protein localization. We have observed partial localization of
Brd2 to the cytoplasm in differentiating P19 cells. Similarly,
cytoplasmic localization of Brd2 has been previously described in
differentiating neurons of the mouse embryo (Crowley et al.,
2004). In addition, Brd2 delocalization was originally reported in
mouse 3T3 cells following serum deprivation (Guo et al., 2000)
and has been also described in the mouse mammary epithelia
during pregnancy (Crowley et al., 2002). Regardless of whether
cytoplasmic localization of Brd2 is a consequence of Ptn
Fig. 6. Ptn destabilizes Brd2 association with chromatin. (A) P19 cells were transfected with a Ptn expression vector (+ Ptn) or the empty vector (Control)
and proteins were consecutively extracted with the indicated NaCl concentrations. The presence of endogenous Brd2 protein in the different extracts was
detected by immunoblotting. (B) Association of endogenous Brd2 protein with the Ccnd1 (cyclin D1) and Ccna2 (cyclin A2) promoters in P19 cells was
determined by chromatin immunoprecipitation (ChIP) with anti-Brd2 antibodies. P19 cells were transfected with Ptn or motif B (mB) expression constructs or
were treated with RA for 48 h (RA) as indicated. Levels were normalized to non-treated cells transfected with empty vector (2). Values are mean6s.d. from three
independent experiments. Statistical significance was assessed by ANOVA, followed by Bonferroni’s post test. Asterisks on top of columns refer to significance
compared with the control (2). ***P#0.001. (C) Extracts from 293T cells transfected with Flag-tagged Brd2 (Flag–Brd2) and HA-tagged Brd2 (HA–Brd2)
constructs together with HA-tagged Ptn (Ptn–HA) or motifB (HA–mB) constructs as indicated were immunoprecipitated with anti-Flag antibodies and co-
immunoprecipitated proteins (coIP) were analyzed by immunoblotting with anti-HA antibodies. The input shows 10% of Flag- and HA-tagged input proteins.
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interaction, what appears relevant to our hypothesis is that Ptn
antagonizes Brd2 nuclear function, that is, the Brd2 cell-cycle-
stimulating activity, which opposes to neuronal differentiation.
Thus, Ptn antagonism should depend on its nuclear localization,
and this aspect has previously been demonstrated for human
endothelial cells (Koutsioumpa et al., 2012) and here revealed for
P19 cells. Moreover, by co-immunoprecipitation experiments
with nuclear extracts we have demonstrated that Ptn and Brd2
interact in the nucleus of RA-treated P19 cells. It is also worth
noting that in the nucleus of differentiating cells we have
determined that Ptn levels are similar to those of Brd2.
Third, there are observations and predictions with regard to
chromatin association. We have previously reported strong
association of Brd2 with chromatin in proliferating P19 cells
(Garcia-Gutierrez et al., 2012). Our results from ChIP experiments
and differential salt extraction demonstrate that Ptn destabilizes the
association of Brd2 with chromatin as a consequence of impaired
dimerization. Either expressing Ptn or competing Brd2 by
expression of a Brd2 fragment encompassing its dimerization
motif B has similar effects on Brd2 association with cyclin
promoters, and both approaches concomitantly show the same
positive effect on induced neuronal differentiation. Interestingly,
Brd3, which appears to be insensitive to Ptn antagonism, interferes
with neuronal differentiation in a similar manner to Brd2, raising
the question about how Ptn stimulates differentiation by selectively
acting on Brd2. Although we have not investigated Brd3 in detail,
it is possible that just interfering with Brd2 might displace the
balance towards differentiation. In fact, Brd2 knockdown has been
shown to promote adipogenic differentiation in 3T3-L1 pre-
adipocytes (Wang et al., 2010). Alternatively, we have previously
demonstrated heterodimerization between different BET family
members and postulated functional consequences linked to this
(Garcia-Gutierrez et al., 2012), suggesting that interfering with one
of the proteins might have broad consequences on BET family
functions. Our demonstration of Ptn-mediated interference with the
dimerization of Brd2 supports this idea. On the other hand, we have
calculated a Ptn:Brd2 ratio of about 1:1 in the nucleus, what might
suggest complete antagonism of Brd2 by Ptn. However, we needed
to overexpress Ptn to obtain the highest differentiation rates,
indicating that the endogenous Ptn pool modulates, rather than
fully inhibits, Brd2 activity. Reported interactions of Brd2 with
several chromatin co-regulators through the ET domain (Rahman
et al., 2011) raise the question of how these factors may alter
Ptn function or interaction. Nevertheless, partial inhibition of
Brd2 activity by Ptn appears to have an effect in facilitating
neurogenesis, since knockdown of Ptn reduces differentiation. In
agreement with this, it has been shown that half the dose of Brd4 or
Brd2 in heterozygous mouse cells has an impact in cell
proliferation (Houzelstein et al., 2002; Shang et al., 2009). Thus,
our results support the idea that relative levels of Brd2 may
influence transcription or signal transduction, as previously
suggested in (Wang et al., 2010).
Finally, there are observations and predictions with regard to
the consequences of Brd2-chromatin destabilization. The release
of BET proteins from chromatin has a negative effect on cell
proliferation. In fact, competing BET association with chromatin
through the synthetic drug JQ1, which mimics specific histone
acetylation marks, has been successfully used to arrest tumor
progression in mice models (Delmore et al., 2011;
Filippakopoulos et al., 2010). It would be of great interest to
investigate the possible application of this synthetic drug as a
novel strategy to enhance neurogenesis following induction of
neuronal differentiation. However, the proliferative defects
associated with knockout of Brd2 (Shang et al., 2009) might
have largely masked evidence for subsequent involvement of
Brd2 in differentiation processes. Our results do not exclude
specific roles of Brd2 during the neuronal differentiation program
because, as mentioned above, Brd2 protein, besides being
detected in neural progenitors in the developing neural tube,
also appears in differentiating neurons along the dorsoventral
axis, including interneurons, motoneurons and sensory neurons
(Crowley et al., 2004). Although several reports have suggested
an involvement of Brd2 in the process of neuronal differentiation
(Gyuris et al., 2009; Tsume et al., 2012; Velı´sˇek et al., 2011),
specific conditional knockout mice are required to accurately
assess this issue. Finally, despite functional redundancy between
Fig. 7. The acidic stretch of Brd2 is conserved in higher vertebrates. (A) Amino acid sequences of different BET proteins from mouse, corresponding to a
region located between the bromodomain 2 and the motif B, were aligned. Amino acids conserved in at least three of the four sequences are shown on a
black background. Acidic stretch in Brd2 is shown on a red background. Numbering indicates amino acid positions. (B) The presence of acidic amino acids (Asp
or Glu) in a fragment of Brd2 proteins from the indicated vertebrate species or mouse Brd4, corresponding to a region located between the bromodomain 2 (red)
and the motif B (blue), was analyzed using the DNA Strider 1.4f6 application. Numbering at both sides indicates amino acid positions flanking each fragment
and numbering above indicates positions within each fragment. Acidic amino acids are represented by vertical black lines. Accession numbers are as follows:
mouse Brd3, NP_001107045; mouse Brd4, NP_065254; mouse Brdt, NP_473395; mouse Brd2 (Mus musculus), NP_034368; human Brd2 (Homo sapiens),
NM_001113182; chick Brd2 (Gallus gallus), NM_001025845; green anoles Brd2 (Anolis carolinensis), XP_003229792; Xenopus Brd2 (Xenopus laevis),
NP_001128282; Medaka fish Brd2 (Oryzias latipes), BAD93258; nurse shark Brd2 (Ginglymostoma cirratum), AEC13624.
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Ptn and Mdk, an interesting developmental phenotype associated
with the single Ptn mutation in mice supports our model: absence
of Ptn results in prolonged proliferation and therefore in impaired
neurogenesis in the cerebral cortex (Hienola et al., 2004).
Similarly, we have shown that Ptn knockdown in P19 cells
impairs induced neuronal differentiation.
Thus, Ptn-mediated Brd2 antagonism seems to modulate
the balance between proliferation and differentiation in
neural progenitors, accounting for appropriate progression into
differentiation at early neurogenesis. Consistently, proteomic
analysis has revealed Brd2 association with proteins known to
play a role in the switch between proliferation and differentiation
(Denis et al., 2006), and it has been suggested that Brd2 is a
candidate protein to regulate ‘stemness’ and proliferation during
hematopoiesis (Belkina et al., 2014). Intriguingly, the exclusive
acidic region in Brd2 that mediates its interaction with Ptn
(Fig. 7A) seems to be restricted to higher vertebrates (Fig. 7B),
suggesting an evolutionary emergence of the Ptn–Brd2 interaction
in higher vertebrates. This is of interest in that neurogenesis
notably differs from higher to lower vertebrates, given that in lower
vertebrates the neuroectodermal primary neurogenesis takes place
before neural tube closing and accumulation of neuronal
progenitors.
MATERIALS AND METHODS
Plasmid constructs and yeast two-hybrid analysis
All transfection constructs, except pEGFP-N1, were derived from vector
pAdRSV-Sp (Giudicelli et al., 2003), with Flag or HA tags. Mouse Brd2,
Brd3, Brd4, Ptn and Mdk cDNAs were obtained by RT-PCR using total
RNA isolated from P19 cells. Brd2 constructs were made by standard
PCR techniques and were as follows: Dacid, deletion (D) of amino acids
475–513; mB, amino acids 463–565. Yeast two-hybrid and X-gal assays
were performed in the DUALhybrid Kit (Dualsystems Biotech,
Schlieren, Zurich, Switzerland) system, using the pLexA-N bait and
pGAD-HA prey vectors, as previously described (Garcia-Gutierrez et al.,
2012). Yeast two-hybrid constructs were generated by standard PCR
techniques and were as follows: Brd2, amino acids 437–798; Brd2Dacid,
amino acids 515–798; Brd2DCter, amino acids 437–517; Brd3, amino
acids 393–726; Brd4, amino acids 437–724; PtnDCter, deletion (D) of
amino acids 143–168. Expression vectors for small hairpin RNA
molecules (shRNA) were based on vector pSuper (OligoEngine,
Seattle, WA, USA). Target sequences were: shPtn, 59-GGAGAAT-
GGCAGTGGAGTG-39; shControl, 59-CCATCAAGACTCATAGATG-
39; and shBrd2, 59-GATCTTCCTGCAGAAGGTG-39.
Protein production and pulldown assays
Production of proteins was conducted in the E. coli BL21 strain.
Purification of the GST–Ptn fusion protein was achieved by incubation
with glutathione–Sepharose 4B matrix (GE Healthcare, Buckinghamshire,
UK) and purification of His-tagged Brd2 protein was achieved by
incubation with HisTrap matrix (GE Healthcare). The GST–Ptn construct
encompassed amino acids 1–168 of Ptn, whereas His-tagged Brd2
encompassed amino acids 50–651 of Brd2. Pull-down experiments with
immobilized GST fusion protein were conducted as previously described
(Garcia-Dominguez et al., 2008).
Cell culture and transfections
Human 293T and mouse P19 cells were cultured in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal bovine serum and a-modified
Eagle’s medium supplemented with 7.5% calf and 2.5% fetal bovine sera,
respectively. Transfections were performed with Lipofectamine 2000
(Invitrogen, Life Technologies, Paisley, UK). All-trans retinoic acid (RA)
was used at 1 mM for 48 or 96 h, as indicated. For transfection monitoring,
the green fluorescent protein expression vector pEGFP-N1 (Clontech,
Mountain View, CA, USA) was used. shPtn or shControl transfections for
Ptn knockdown were performed 24 h before RA treatment.
Cell extracts and immunoprecipitation
For differential salt extraction, P19 cells were first extracted with buffer
A [50 mM Tris-HCl pH 7.5, 1% Triton X-100, complete protease
inhibitor cocktail (Roche, Mannheim, Germany)] supplemented with
100 mM NaCl. The pellet was then extracted with the same buffer
containing 520 mM NaCl. The procedure to obtain nuclear and
cytoplasmic extracts was as described by Alfonso-Perez et al.
(Alfonso-Pe´rez et al., 2013). Whole-cell extracts were obtained by
lysing cells in urea buffer (10 mM Tris-HCl pH 8.0, 8 M urea). Protein
concentration was determined by the Bradford reactive assay (Bio-Rad,
Hercules, CA, USA). Extracts were separated by SDS-PAGE and
analyzed by immunoblotting. For immunoprecipitation, 96105 cells were
extracted with 250 ml of buffer A containing 150 mM NaCl. Then, NaCl
concentration was increased to 600 mM drop wise. Supernatant was
recovered and diluted 3-fold with buffer B [50 mM Tris-HCl pH 7.5,
Complete protease inhibitor cocktail (Roche)] and incubated overnight
with the respective antibodies: anti-Flag M2 Affinity Gel (Sigma-
Aldrich, St Louis, MO, USA), anti-Brd2I rabbit antibodies (see below) or
pre-immune serum. Rabbit antibodies were precipitated with rProtein A
Sepharose4 Fast Flow matrix (GE Healthcare). After washing, proteins
were eluted with 20 ml of SDS-containing Laemmli buffer and analyzed
by immunoblotting.
Antibody generation and immunoblotting
Antibodies against Brd2 were produced in rabbit after immunization with
a peptide corresponding to amino acids 698–780 (anti-Brd2C) (Garcia-
Gutierrez et al., 2012), 50–651 (anti-Brd2N) or 164–274 (anti-Brd2I) of
the mouse Brd2 protein or amino acids 628–713 of the chick Brd2
protein. Immunoblotting was conducted on PVDF membranes (Bio-Rad)
using the chemiluminescent ECL system (GE Healthcare), according to
the manufacturer’s instructions. A ChemiDocXRS apparatus (Bio-Rad)
was used for chemiluminescence measurement. Antibodies were: rabbit
anti-Brd2C (1:500), rabbit anti-Brd2I (1:500), mouse anti-Flag M2
(1:2000, Sigma-Aldrich), mouse anti-His (1:1000, GE Healthcare),
mouse anti-a-tubulin (1:1000, Sigma-Aldrich), goat anti-Ptn C-19
(1:500, sc-1394, Santa Cruz Biotechnology, Santa Cruz, CA), rat anti-
HA (1:2000, Roche), goat anti-Baf155 R-18 (1:1000, sc-9746, Santa
Cruz Biotechnology) rabbit anti-bIII-tubulin (neuron specific, 1:500,
Abcam, Cambridge, UK), rabbit anti-Oct3/4 H-134 (1:1000, sc-9081,
Santa Cruz Biotechnology), and horseradish peroxidase (HRP)-
conjugated goat anti-rabbit Ig, goat anti-rat Ig, goat anti-mouse Ig and
rabbit anti-goat Ig antibodies (1:10,000, Sigma-Aldrich).
Chromatin immunoprecipitation and quantitative PCR
A total of 107 P19 cells fixed in 1% formaldehyde for 10 min at 37 C˚
were used in each experiment. The chromatin was immunoprecipitated
with anti-Brd2N antibodies (1:50) and rProtein A Sepharose4 Fast Flow
(GE Healthcare). Quantitative PCR was used for analysis of the Ccnd1
and Ccna2 promoters. Real-time PCR reactions were performed with the
SensiMix SYBR Low-ROX kit (Bioline, London, UK) in the Applied
Biosystems (Carlsbad, CA, USA) 7500 FAST Real-Time PCR System.
Precipitation with pre-immune serum was used for normalization.
Algorisms for calculation of relative units and normalization of values
according to primer efficiency were as previously described (Pfaffl,
2001). Sequences of primers were: Ccna2-F 59-CCAGCGTTTCCCTA-
TGTTGT-39; Ccna2-R 59-CTAGGCAGGAGCGTATGGAT-39; Ccnd1-F
59-GGAGGACCCTCTTAGGGAAA-39; Ccnd1-R 59-GGAGGACCCTC-
TTAGGGAAA-39.
In ovo electroporation, immunofluorescence and b-
galactosidase assay
Electroporation, preparation of embryos and immunofluorescence on
neural tube sections or P19 cells were conducted as described previously
(Farah et al., 2000; Garcia-Dominguez et al., 2003). All animal
experiments were performed according to approved guidelines.
For electroporation monitoring, the green fluorescent protein
expression vector pEGFP-N1 (Clontech) was used at a concentration of
0.3 mg/ml. Antibodies were: mouse anti-Flag M2 (1:250, Sigma-Aldrich),
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rat anti-HA (1:250, Roche), rabbit anti-Brd2C (1:200), rabbit anti-chick
Brd2 (1:200), rabbit anti-neuron specific bIII-Tubulin (1:500, Abcam),
goat anti-Ptn C19 (1:200, sc-1394, Santa Cruz Biotechnology), donkey
anti-rat Ig and anti-rabbit Ig conjugated to DyLight-549 (1:800, Jackson
Immunoresearch, Suffolk, UK), donkey anti-goat Ig and anti-mouse
Ig conjugated to DyLight-488 (1:800, Jackson Immunoresearch), and
donkey anti-rabbit Ig conjugated to DyLight-649 (1:800, Jackson
Immunoresearch). Cell nuclei were exposed by DAPI staining.
Fluorescent images of cells and embryo sections were acquired on Leica
Microsystems GmbH (Wetzlar, Germany) epifluorescence DM6000 and
confocal TCS SP5 microscopes, respectively. Images were from a single
focal plane in both cases, and were processed with Leica LAS AF and
Adobe Photoshop software. For b-galactosidase detection, the embryos
were fixed for 20 min in 4% paraformaldehyde and stained with X-gal as
previously described (Schneider-Maunoury et al., 1993).
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